These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Seizures as a manifestation of systemic disease. Messing RO; Simon RP Neurol Clin; 1986 Aug; 4(3):563-84. PubMed ID: 3092002 [TBL] [Abstract][Full Text] [Related]
5. The clinical use of synthetic 1,25-dihydroxycholecalciferol. Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663 [No Abstract] [Full Text] [Related]
9. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis]. Fournier A; Bordier P; Weil B; Safar M; Idatte JM Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047 [No Abstract] [Full Text] [Related]
10. [Adynamic bone disease and relative hypoparathyroidism in uremia]. Mora C; Navarro JF Nefrologia; 2001; 21(1):26-40. PubMed ID: 11344959 [No Abstract] [Full Text] [Related]
11. [Anomalies of phosphate and calcium metabolism in chronic renal insufficiency]. Drüeke TB Rev Prat; 1998 Jun; 48(11):1207-12. PubMed ID: 9781173 [TBL] [Abstract][Full Text] [Related]
13. A clinical approach to common electrolyte problems: 3. Hypophosphatemia. Berkelhammer C; Bear RA Can Med Assoc J; 1984 Jan; 130(1):17-23. PubMed ID: 6418367 [TBL] [Abstract][Full Text] [Related]
14. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749 [No Abstract] [Full Text] [Related]
15. Multiple drug interactions with phenytoin. Birkett DJ; Graham GG; Chinwah PM; Wade DN; Hickie JB Med J Aust; 1977 Oct; 2(14):467-8. PubMed ID: 600148 [TBL] [Abstract][Full Text] [Related]
16. [Hypophosphatemia. A review (author's transl)]. Sibille M Anesth Analg (Paris); 1979; 36(7-8):289-300. PubMed ID: 118683 [TBL] [Abstract][Full Text] [Related]
17. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3. Madsen S Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650 [No Abstract] [Full Text] [Related]
19. Changes in serum phosphate during treatment of diabetic ketoacidosis: predictive significance of severity of acidosis on presentation. Shen T; Braude S Intern Med J; 2012 Dec; 42(12):1347-50. PubMed ID: 23252999 [TBL] [Abstract][Full Text] [Related]
20. [Manifestations in metabolic bone diseases]. Steiger U Verh Dtsch Ges Rheumatol; 1974; 3(0):135-41. PubMed ID: 4406950 [No Abstract] [Full Text] [Related] [Next] [New Search]